Search

Your search keyword '"Ferreira, Joaquim J."' showing total 1,446 results

Search Constraints

Start Over You searched for: Author "Ferreira, Joaquim J." Remove constraint Author: "Ferreira, Joaquim J."
1,446 results on '"Ferreira, Joaquim J."'

Search Results

401. Identification of genetic variants associated with Huntington's disease progression: a genome-wide association study

403. Substantia Nigra Neuromelanin as an Imaging Biomarker of Disease Progression in Parkinson’s Disease

408. Placebo and nocebo responses in restless legs syndrome

409. Algorithm for Turning Detection and Analysis Validated under Home-Like Conditions in Patients with Parkinson’s Disease and Older Adults using a 6 Degree-of-Freedom Inertial Measurement Unit at the Lower Back

412. Safety and efficacy of incobotulinumtoxinA doses up to 800 U in limb spasticity

414. Frequency of falls in nursing homes for neurodegenerative diseases

417. Feasibility study of an intensive multi-strategy rehabilitation program for Parkinson disease

418. Swimming is compromised in Parkinson's disease patients.

419. Measurement Instruments to Assess Functional Mobility in Parkinson's Disease: A Systematic Review.

420. MDS evidence-based review of treatments for essential tremor.

421. A critique of the second consensus criteria for multiple system atrophy.

422. Validation of a step detection algorithm during straight walking and turning in Patients with Parkinson's disease and older adults using an inertial measurement unit at the lower back

423. Algorithm for turning detection and analysis validated under home-like conditions in patients with Parkinson's disease and older adults using a 6 degree-of-freedom inertial measurement unit at the lower back

424. Clinical Practice:Evidence-Based Recommendations for the Treatment of Cervical Dystonia with Botulinum Toxin

425. Identification of genetic variants associated with Huntington's disease progression: a genome-wide association study

426. Clinical practice: Evidence-based recommendations for the treatment of cervical dystonia with botulinum toxin

427. Algorithm for Turning Detection and Analysis Validated under Home-Like Conditions in Patients with Parkinson?s Disease and Older Adults using a 6 Degree-of-Freedom Inertial Measurement Unit at the Lower Back

429. Aspirin for Primary Cardiovascular Prevention in Patients with Family History of Cardiovascular Disease: Meta-analysis.

430. Subthalamic deep brain stimulation effects on odor identification in Parkinson's disease

431. Quantitative analysis versus visual assessment of Neuromelanin MR Imaging for the diagnosis of Parkinson’s disease

432. Clinical pharmacology review of safinamide for the treatment of Parkinson’s disease

433. Clinical parameters and tools for home-based assessment of Parkinson’s disease: results from a Delphi study

434. Ethyl-eicosapentaenoic acid treatment in Huntington's disease: a placebo-controlled clinical trial

435. Systematic review with meta-analysis : the risk of major gastrointestinal bleeding with non-vitamin K antagonist oral anticoagulants

436. Substantia nigra neuromelanin-MR imaging differentiates essential tremor from Parkinson's disease

437. Opicapone to Treat Early Wearing‐off in Parkinson's Disease Patients: The Korean ADOPTION Trial.

438. Prevalência da anticoagulação oral em doentes com fibrilhação auricular em Portugal : revisão sistemática e meta-análise de estudos observacionais

439. Clinical Practice: Evidence-Based Recommendations for the Treatment of Cervical Dystonia with Botulinum Toxin

444. Dysarthria in individuals with Parkinson's disease: a protocol for a binational, cross-sectional, case-controlled study in French and European Portuguese (FraLusoPark)

446. Efficacy and safety of abobotulinumtoxinA liquid formulation in cervical dystonia: A randomized-controlled trial

449. Erratum to: A systematic review of the characteristics and validity of monitoring technologies to assess Parkinson’s disease

Catalog

Books, media, physical & digital resources